Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...

A recent study has found that a class of diabetes drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors may ... such as diabetic ketoacidosis, sepsis, and kidney injury.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

9,10 The hyperinsulinemic-euglycemic clamp test was performed to determine precisely which tissues are affected. The goal of the euglycemic insulin clamp test is to raise the plasma insulin ...